3D visualization of internal defects in concrete to help improve aging infrastructure
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Apr-2026 12:16 ET (3-Apr-2026 16:16 GMT/UTC)
A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage has occurred. The biological processes leave measurable traces in the blood, but only for a limited period. The discovery thus reveals a window of opportunity that could be crucial for future treatment, but also for early diagnosis via blood tests, which could begin to be tested in healthcare within five years.